Lexpos News

Pharmacy Press This month we celebrate South Asian Heritage Month, a time to honor the cultural contributions of South Asian communities in England. At Community Pharmacy England, we recognise our colleagues’ diverse journeys and experiences in community pharmacy and their significant contributions to our sector. In honour of this and this year’s theme, “Free to [...]

The post Celebrating South Asian Heritage Month 2024 appeared first on Community Pharmacy England.

Community Pharmacy England has set out the value, challenges and opportunities for the sector in its submission to Lord Darzi’s review of the NHS. The independent investigation of NHS performance, commissioned by the Secretary of State for Health and Social Care, is examining the challenges facing the healthcare system ahead of the development of a [...]

The post Community Pharmacy England makes submission to NHS review appeared first on Community Pharmacy England.

Pharmacy owners and LPCs are encouraged to make use of the current break in Parliamentary activity to engage with their local MPs. Following the General Election, Community Pharmacy England has contacted all new and returning MPs of English constituencies to congratulate them on their respective election victories and seek their support for pharmacy over the [...]

The post Help raise awareness of pharmacy issues: Invite your MP to visit appeared first on Community Pharmacy England.

Class 4 Medicines Defect Information: Diflucan Oral Suspension 40mg/ml (Star Pharmaceuticals Limited) Drug alert number: EL (24)A/36 Date issued: 12 August 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Diflucan Oral Suspension 40mg/ml (Star Pharmaceuticals Limited) Company name: Star Pharmaceuticals Limited Product name: Diflucan Oral [...]

The post MHRA Class 4 Medicines Defect Information: Diflucan Oral Suspension 40mg/ml (Star Pharmaceuticals Limited) appeared first on Community Pharmacy England.

Currently all branded and generically written prescriptions for Rivaroxaban tablets are reimbursed in line with NHS list prices of the brand originator Xarelto®. However, licensed generic Rivaroxaban tablets have been available in the market for several months following the patent expiry of Xarelto®. Consequently, selling prices of generic Rivaroxaban tablets have fallen sharply when compared [...]

The post Rivaroxaban tablets – changes to reimbursement from September 2024 appeared first on Community Pharmacy England.